loadpatents
Patent applications and USPTO patent grants for Brady; Stephen F..The latest application filed is for "conjugates useful in the treatment of prostate cancer".
Patent | Date |
---|---|
Beta-secretase substrates and uses thereof Grant 7,479,372 - Brady , et al. January 20, 2 | 2009-01-20 |
Conjugates useful in the treatment of prostate cancer App 20070244055 - Brady; Stephen F. ;   et al. | 2007-10-18 |
Beta-secretase substrates and uses thereof App 20070184488 - Brady; Stephen F. ;   et al. | 2007-08-09 |
Conjugates useful in the treatment of prostate cancer App 20070129309 - Brady; Stephen F. ;   et al. | 2007-06-07 |
.beta.-secretase inhibitors Grant 7,205,336 - Lai , et al. April 17, 2 | 2007-04-17 |
Conjugates useful in the treatment of prostate cancer App 20070021350 - Brady; Stephen F. ;   et al. | 2007-01-25 |
Beta-secretase substrates and uses thereof Grant 7,132,401 - Brady , et al. November 7, 2 | 2006-11-07 |
Conjugates useful in the treatment of prostate cancer App 20060148718 - Brady; Stephen F. ;   et al. | 2006-07-06 |
Conjugates useful in the treatment of prostate cancer App 20050119166 - Brady, Stephen F. ;   et al. | 2005-06-02 |
Beta-secretase substrates and uses thereof App 20050032190 - Brady, Stephen F. ;   et al. | 2005-02-10 |
Conjugates useful in the treatment of prostate cancer App 20040081659 - Brady, Stephen F. ;   et al. | 2004-04-29 |
Conjugates useful in the treatment of prostate cancer Grant 6,174,858 - Brady , et al. January 16, 2 | 2001-01-16 |
Conjugates useful in the treatment of prostate cancer Grant 6,127,333 - Brady , et al. October 3, 2 | 2000-10-03 |
Thrombin inhibitors Grant 5,798,377 - Lumma , et al. August 25, 1 | 1998-08-25 |
Pyridinone thrombin inhibitors Grant 5,792,779 - Sanderson , et al. August 11, 1 | 1998-08-11 |
Piperidine and hexahydropyridazine thrombin inhibitors Grant 5,714,485 - Lumma , et al. February 3, 1 | 1998-02-03 |
Thrombin inhibitors Grant 5,672,582 - Veber , et al. September 30, 1 | 1997-09-30 |
Thrombin inhibitors Grant 5,629,324 - Vacca , et al. May 13, 1 | 1997-05-13 |
Pyrrolidine thrombin inhibitors Grant 5,510,369 - Lumma , et al. April 23, 1 | 1996-04-23 |
Peptides having atrial natriuretic factor activity Grant 5,204,328 - Nutt , et al. April 20, 1 | 1993-04-20 |
Peptides having ANF activity Grant 5,091,366 - Nutt , et al. February 25, 1 | 1992-02-25 |
Fibrinogen receptor antagonists Grant 5,061,693 - Nutt , et al. October 29, 1 | 1991-10-29 |
Fibrinogen receptor antagonists Grant 5,023,233 - Nutt , et al. June 11, 1 | 1991-06-11 |
Piptides having ANF activity Grant 4,816,443 - Brady , et al. March 28, 1 | 1989-03-28 |
Cyclic hexapeptides Grant 4,108,987 - Veber , et al. August 22, 1 | 1978-08-22 |
Synthetic antigens of luteinizing hormone releasing hormone Grant 3,963,691 - Hoffman , et al. June 15, 1 | 1976-06-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.